103
Participants
Start Date
June 28, 2019
Primary Completion Date
June 25, 2024
Study Completion Date
December 31, 2025
Radiation
"35 fractions, 5/wk, 7 wks 70Gy/56Gy, or~35 fractions, 6/wk, 6 wks, 70Gy/56Gy, or~35 fractions, 5/wk, 7 wks OR 6/wk, 6 wks 70Gy/56Gy"
Cisplatin
100 mg/m2 on day 1, 22, and 43 or 40 mg/m2 /wk for 7 wks
BCCA - Centre for the North, Prince George
BCCA - Vancouver Cancer Centre, Vancouver
CancerCare Manitoba, Winnipeg
Dr. H. Bliss Murphy Cancer Centre, St. John's
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Kingston Health Sciences Centre, Kingston
Ottawa Hospital Research Institute, Ottawa
Odette Cancer Centre, Toronto
University Health Network, Toronto
The Jewish General Hospital, Montreal
The Research Institute of the McGill University, Montreal
Hotel-Dieu de Quebec, Québec
CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke
Allan Blair Cancer Centre, Regina
Canadian Cancer Trials Group
NETWORK